Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Novocure Ltd Ord Sh (NVCR)

Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Novocure Ltd Ord Sh NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF JEY

www.novocure.com Employees: 1,488 P: 44-0-15-3475-6700

Sector:

Medical

Description:

NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.

Key Statistics

Overview:

Market Capitalization, $K 1,518,476
Enterprise Value, $K 1,449,686
Shares Outstanding, K 111,982
Float, K 105,801
% Float 94.48%
Short Interest, K 8,334
Short Float 7.44%
Days to Cover 7.82
Short Volume Ratio 0.38
% of Insider Shareholders 5.52%
% of Institutional Shareholders 84.61%

Financials:

Annual Sales, $ 605,220 K
Annual Net Income, $ -168,630 K
Last Quarter Sales, $ 167,200 K
Last Quarter Net Income, $ -37,270 K
EBIT, $ -176,710 K
EBITDA, $ -191,120 K

Growth:

1-Year Return -46.80%
3-Year Return -85.08%
5-Year Return -91.58%
5-Year Revenue Growth 72.27%
5-Year Earnings Growth -2,128.57%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.33 on 10/30/25
Next Earnings Date 02/26/26
Earnings Per Share ttm -1.61
EPS Growth vs. Prev Qtr 8.33%
EPS Growth vs. Prev Year -17.86%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NVCR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -50.29%
Return-on-Assets % -13.94%
Profit Margin % -27.86%
Debt/Equity 0.57
Price/Sales 2.34
Price/Cash Flow N/A
Price/Book 4.27
Book Value/Share 3.05
Interest Coverage -4.33
60-Month Beta 0.73
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar